LA JOLLA, Calif., July 30, 2020 (GLOBE NEWSWIRE) — Equillium, Inc. (Nasdaq: EQ), a clinical-stage biotechnology company leveraging deep understanding […]
Highlights: Improving freight volumes as the quarter progressed, coupled with revenue enhancement and profit improvement initiatives, as well as strong cost […]
Second Quarter HighlightsTotal revenue of $258.4 million, up 21% year-over-yearBillings of $250.0 million, up 8% year-over-yearGAAP EPS of $(0.39) per […]